OpenResearchAlpha

bioRxiv · 13 Nov 2026

Antibody design across observed and forecasted antigenic evolution

Soyoon Parkh-index 4, Talal M Widatalla, Claudia Driscoll, Luis Santiago Mille-Fragoso, Ivan Specht, Xiaojing J Gao, Brian Hieh-index 29

0
Citations
no database records one yet
0
Citations in 2026
so far
29
Leading author's h-index
Brian Hie, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

The therapeutic efficacy of antibodies is often limited by the evolution of their targets. Designing or eliciting antibodies that withstand such evolution is challenging as their binding interfaces must accommodate antigenic variation. Here, we introduce Germinal Multi, a computational framework for de novo antibody design and rescue that jointly optimizes a single paratope against multiple antigenic variants. We applied Germinal Multi to cancer and viral antigens, targeting both observed antigenic variation and prospective antibody escape. Multi-target optimization yielded antibodies that bound resistance-associated EGFR variants or that neutralized antigenically distinct historical SARS-CoV-2 variants, with recognition extending to variants withheld from the design process. Beyond acting on observed evolution, we redesigned the broadly neutralizing antibody BD55-1205 to restore neutralization of a prospective escape variant engineered with guidance from an evolutionary forecasting model, while preserving activity against the parental variant. Successful candidates were identified after screening tens of designs per campaign. Together, these results establish multi-target computational design as a strategy for generating antibody breadth across observed antigenic variation and demonstrate the potential of evolutionary forecasting to guide antibody redesign against prospective escape.

Synthetic biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Brian Hie has the highest h-index among the authors (29).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (7)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
Antibody design across observed and forecasted antigenic evolution - QAI OpenResearch